abstract |
The present invention relates to topical compositions comprising erythrulose and a retinyl ester selected from the group consisting of retinyl acetate, retinyl propionate, retinyl linoleate, retinyl retinoate and / or retinyl aspartamate. formyl, preferably retinyl acetate, and their use for the prevention and / or treatment of diseases associated with overcrowding of microbial cells such as fungi and bacteria. |